Medicare’s "Bridge" Program Offers Temporary Lifeline for GLP-1 Weight Loss Drugs, But Questions Linger

For years, Medicare beneficiaries seeking the groundbreaking GLP-1 medications for weight loss faced a definitive "no." However, a new initiative, dubbed the "Medicare GLP-1 Bridge short-term demonstration," is poised to change that narrative, albeit with significant caveats. Starting July 1, 2026, eligible individuals will gain access to certain GLP-1 drugs, like Wegovy (which shares the…

Read More

The Hidden Cost of Retirement: Navigating the Medicare IRMAA Surcharge

For years, as a writer and editor for Kiplinger Personal Finance, I have dedicated my career to warning readers about the looming, often staggering out-of-pocket healthcare costs that accompany retirement. It is a fundamental pillar of financial planning: understand your liabilities before you exit the workforce. Fidelity Investments underscores this reality with sobering data, estimating…

Read More